• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Model Number 12220
Device Problems No Apparent Adverse Event (3189); Insufficient Information (3190)
Patient Problems Tachycardia (2095); Alteration in Body Temperature (4568)
Event Date 06/16/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is in process, a follow-up report will be provided.
 
Event Description
The customer sent a request to terumo bct customer support requesting a machine check out because there was a patient blood reaction during a red blood cell exchange (rbcx) procedure.The physician stopped the procedure and was going to do a transfusion work up.The patient experienced elevated heart (hr) rate and temperature (t).During the procedure the hr was 170 and the t was 38.6 c and prior to the procedure hr was 140 and t was 36.9 c.The patient was given tylenol 650 mg, aspirin 325 mg, and benadryl 25 mg.The patient is in stable condition.The collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information in investigation: further evaluation of this event has determined that the device did not cause or contribute to a death or serious injury, nor is there a likely potential for death or serious injury associated with this event based on additional investigational information.It was confirmed that no unplanned prescription medication was given.No further reporting will be provided as this does not represent a reportable event.A disposable complaint history search was performed for this lot and found no reports for similar issues on this lot worldwide.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Per follow up from the customer, the physician ordered the procedure to be stopped and a transfusion work up was ordered, blood and urine cultures were drawn and the results from the lab were negative.No unplanned prescription medication was given.Root cause: a root cause assessment was performed for this complaint.Based on the available information a definitive root cause could not be determined but it is likely due to one or a combination of the possible causes listed below: * patient physiology/disease state * febrile reactions occur more frequently in patients receiving non-leukocyte-reduced components and those previously alloimunized by transfusion or pregnancy.It is likely the reactions were caused by the presence of recipient antibodies (raised as a result of previous transfusions) reacting to donor human leucocyte antigens (hla) or other antigens.It is also widely known that febrile reactions are caused by passively transfused cytokines or recipient antibodies reacting with leukocytes in the blood product.
 
Event Description
The customer sent a request to terumo bct customer support requesting a machine check out because there was a patient blood reaction during a red blood cell exchange (rbcx) procedure.The physician stopped the procedure and was going to do a transfusion work up.The patient experienced elevated heart (hr) rate and temperature (t).During the procedure the hr was 170 and the t was 38.6 c and prior to the procedure hr was 140 and t was 36.9 c.The patient was given tylenol 650 mg, aspirin 325 mg, and benadryl 25 mg.The patient is in stable condition.The collection set is not available for return because it was discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key17342289
MDR Text Key319377696
Report Number1722028-2023-00240
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 07/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/18/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number12220
Device Catalogue Number4122201
Device Lot Number2302223141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/20/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/22/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age33 YR
Patient SexMale
Patient Weight79 KG
-
-